A tuberculin skin test (TST), commonly called a Mantoux test or PPD test, cannot give you tuberculosis or cause a systemic illness. The test works by injecting a tiny amount of inactive protein under the skin of your forearm, not live bacteria. That said, the test is designed to provoke an immune reaction in people who have been exposed to TB, and that reaction can produce uncomfortable local symptoms that feel like something is wrong. Understanding which responses are normal, which are uncommon but harmless, and which rare reactions deserve medical attention can save you a lot of unnecessary worry.
What the Test Actually Puts in Your Body
The substance injected during a TB skin test is called purified protein derivative, or PPD. It is a mix of proteins extracted from the bacterium that causes tuberculosis, but the proteins themselves are biologically inert. They cannot reproduce, infect tissue, or cause TB disease. The injection goes just beneath the surface of the skin on the inner forearm, forming a small, pale bump called a wheal that usually disappears within minutes. Your body then has 48 to 72 hours to mount an immune response to those proteins, and a healthcare worker reads the result by measuring any firm swelling (induration) that develops at the injection site.
The Normal Immune Response and Why It Can Feel Unpleasant
If your immune system has previously encountered TB bacteria, either through infection or through BCG vaccination, it recognizes the injected proteins and sends immune cells to the site. This is a delayed-type hypersensitivity reaction. The area around the injection becomes firm, raised, and sometimes red. Research on this reaction shows that monocytes, macrophages, and lymphocytes flood the injection site, releasing inflammatory signaling molecules. The main cytokine driving the response is interferon-gamma, produced by both CD4+ and CD8+ T cells.1PubMed Central. A Comparative Study on the Mechanism of Delayed-Type Hypersensitivity Mediated by the Recombinant Mycobacterium tuberculosis Fusion Protein ESAT6-CFP10 and Purified Protein Derivative
In practical terms, this means you might experience itching, warmth, mild soreness, or a visible red patch around the injection. These sensations are the point of the test. They are evidence that your immune system is responding, not evidence that something has gone wrong. The discomfort is usually mild and localized to a small area of your forearm. It is not a sign of illness, and it does not spread.
If you have never been exposed to TB and have not had a BCG vaccine, you will likely have no reaction at all beyond a brief sting from the needle. The injection site may remain completely flat and unmarked.
Severe Local Reactions
Occasionally, the skin reaction goes beyond ordinary redness and swelling. In a study of patients undergoing tuberculin skin testing, about 3.5% developed blistering and necrosis at the injection site. The same study identified generalized urticaria (hives spreading beyond the injection site) in roughly 3.5% of cases, angioedema in about 2.6%, and a granulomatous reaction in under 1%.2Indian Journal of Public Health. Tuberculin Skin Testing These reactions are uncommon, but they are worth knowing about because blistering at the test site can look alarming if you are not expecting it.
A strongly positive reaction with blistering is generally associated with a high degree of prior sensitization to TB proteins. It does not mean the test itself harmed you in a lasting way, but it does mean you should let the reading clinician know, as it affects how the result is interpreted and may warrant follow-up. If you develop hives away from the injection site, facial swelling, or difficulty breathing, seek medical attention. True anaphylaxis from a tuberculin test is extraordinarily rare, but it has been reported.
Fainting and Needle-Related Reactions
Some people feel lightheaded, dizzy, or nauseated during or shortly after any needle procedure, and a TB skin test is no exception. This is a vasovagal response triggered by anxiety or the sensation of a needle entering the skin, not by the PPD itself. In a study of people undergoing needle procedures, about 3% experienced severe vasovagal symptoms including actual fainting.3PubMed Central. Predicting Vasovagal Reactions to Needles from Facial Action Units
If you have a history of feeling faint around needles, mention it beforehand. Sitting or lying down during the injection and staying seated for a few minutes afterward usually prevents a full faint. This reaction has nothing to do with tuberculosis or the test solution. You would get the same response from a flu shot or a blood draw if needles are your trigger.
The 48-to-72-Hour Reading Window
After the injection, you wait. The test is read by a healthcare worker who runs a finger across the injection site and measures the diameter of any induration, the firm raised area beneath the skin. You need to return within a specific window for this reading, and timing matters more than most people realize.
A study comparing readings at 48 and 72 hours found that about 35% of patients showed a measurable difference between the two time points. When differences existed, the induration was larger at 72 hours in 86% of cases. In a small but clinically meaningful fraction, roughly 3.7%, the test flipped from negative at 48 hours to positive at 72 hours.4PubMed Central. Tuberculin Test Measurement at 48 and 72 hours: mismatch and clinical significance This means that showing up too early for your reading could lead to a falsely negative result. If your clinic schedules a 48-hour reading and you have concerns, it is reasonable to ask whether a 72-hour reading is an option.
During the waiting period, avoid scratching, scrubbing, or covering the site with a bandage. Some itching is normal and does not mean the test is positive. Only the measured induration determines the result, not redness or itchiness on its own.
How BCG Vaccination Complicates Things
If you received the BCG vaccine, which is standard in many countries outside the United States, your immune system may react to the TB skin test proteins even though you do not have a TB infection. A meta-analysis found that people who had been vaccinated with BCG were roughly twice as likely to have a positive skin test result compared to unvaccinated individuals.5PubMed Central. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements The same analysis found that BCG’s influence on the test faded significantly after 15 years, and that indurations larger than 15 millimeters were more likely to reflect actual TB infection than vaccine effect.
A separate study sharpened this point further, finding that among people under 40, skin test reactions up to 18 millimeters in diameter were more likely caused by prior BCG vaccination than by genuine TB infection.6Clinical Infectious Diseases. Influence of Bacille Calmette-Guérin Vaccination on Size of Tuberculin Skin Test Reaction: To What Size? This is one reason why clinicians in the United States often prefer blood-based TB tests (interferon-gamma release assays, or IGRAs) for people with a BCG history. Those blood tests are not thrown off by prior vaccination.
The practical takeaway: if you had a BCG vaccine as a child and your skin test comes back positive, it does not necessarily mean you are infected. But it does mean your doctor will likely recommend additional testing, usually a chest X-ray or an IGRA blood test, before drawing conclusions. The skin test itself did not make you sick; it just responded to an immune memory that might be from the vaccine rather than from TB.
The Booster Effect With Repeated Tests
People who undergo TB skin tests regularly, such as healthcare workers, sometimes notice that their reaction grows larger with successive tests. This is called the booster phenomenon, and it can look like a new infection when it is actually the immune system “remembering” a prior exposure more strongly the second time around.
A study of nearly 1,500 hospital employees across the United States found that boosting occurred in all age groups but increased with age. The boosted reactions appeared as soon as one week after an initial test and were attributed either to remote TB infection or to past sensitization by nontuberculous mycobacteria.7Oxford Academic. The Booster Phenomenon in Serial Tuberculin Testing In other words, the first test “woke up” an immune memory that had been dormant, and the second test caught that awakened response.
To address this, occupational health programs that require serial testing often use a two-step baseline approach. You get tested once, then tested again one to three weeks later. The second result becomes your baseline. That way, if a future test is larger, clinicians can be more confident that the increase reflects a genuine new exposure rather than a boosted old memory.8International Journal of Mycobacteriology. Safety of the two-step tuberculin skin test in Indian health care workers The boosted reaction itself is not dangerous and does not mean the test harmed you. It is just your immune system flexing a muscle it hadn’t used in a while.
Live Vaccines Can Temporarily Alter Your Results
If you recently received a live-virus vaccine, such as the measles-mumps-rubella (MMR) vaccine or the varicella vaccine, your TB skin test results could be unreliable for a period of time. Live viral vaccines have long been known to temporarily suppress the delayed-type hypersensitivity response that the TB test relies on. Measles virus in particular has been associated with a transient impairment of skin test reactivity to PPD.9Cellular Immunology. Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus: A reexploration of the phenomenon
Interestingly, a large study of children undergoing immigration medical exams found that the interaction is more complicated than simple suppression. Children tested in the weeks following live-virus vaccination actually had higher rates of positive TB skin test results compared to children tested outside that window: about 15.7% tested positive during the post-vaccination interval versus roughly 7% tested later.10PubMed Central. The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results? The researchers had expected the opposite, raising questions about whether the post-vaccination immune activation might inflate rather than suppress TST results in some populations. The CDC’s general guidance has been to either perform the TB test on the same day as the live vaccine or wait at least four weeks, but this study suggests the timing question is more nuanced than previously assumed.
None of this means a vaccine “made you sick” through the TB test. It means the immune system is in a temporarily altered state, and test timing can affect accuracy. If you recently received a live vaccine and need a TB test, let your provider know so they can account for potential interference.
When Immune Suppression Makes the Test Unreliable
The TB skin test depends on a functioning immune system to produce a reaction. In people whose immune systems are compromised, the test can come back falsely negative, meaning it shows no reaction even though the person is actually infected with TB. HIV infection is the most well-studied example: tuberculin skin testing may be false negative in immunocompromised patients, including those with HIV.11PubMed Central. Significance of Tuberculin Testing in HIV Infection: An Indian Perspective
This applies to other forms of immune suppression as well, including organ transplant recipients on anti-rejection drugs, people receiving chemotherapy, and those on high-dose corticosteroids. In these situations, a negative TB test does not reliably rule out infection, and providers typically turn to blood-based IGRA tests or imaging as alternatives. The test is not more dangerous for immunocompromised people; it is just less useful because the immune system cannot mount the reaction the test is designed to detect.
Symptoms That Are Not From the Test
After a TB skin test, people sometimes develop symptoms like a mild headache, fatigue, or a low-grade fever and wonder whether the test caused them. In nearly all cases, these symptoms are coincidental. A tiny intradermal injection of inactive protein does not cause systemic illness. If you develop a fever, cough, or body aches in the days after a TB test, you likely caught something unrelated. The timing is a coincidence, not a connection.
The one exception is a severe allergic reaction, which would appear within minutes to hours, not days. Symptoms of anaphylaxis include difficulty breathing, widespread hives, throat tightening, and a rapid drop in blood pressure. If those appear shortly after the injection, that is a medical emergency. But this scenario is vanishingly rare. Most healthcare providers who administer TB tests regularly have never witnessed one.
It is also worth noting that the test cannot reactivate a latent TB infection. If you carry latent TB, the small amount of protein injected during the test does not wake up dormant bacteria or trigger active disease. The proteins are fragments of the bacterium, not the bacterium itself. They provoke an immune response at the injection site, and that is where the story ends.
Why Some People Get Stronger Reactions Over Time
Beyond the booster phenomenon discussed earlier, some individuals notice that their reactions grow progressively larger across years of repeated testing. Occupational health workers, prison staff, and immigration screeners are among those tested most frequently and most likely to notice this pattern. Part of the explanation is straightforward: with each exposure to PPD, the immune system becomes more sensitized to it. But another part is epidemiological. The longer someone works in a high-exposure setting, the more likely they are to have encountered actual TB bacteria at some point, which would independently increase the reaction size.
Distinguishing between these two causes, sensitization to the test protein itself versus genuine new infection, is one of the persistent headaches in TB screening programs. The two-step baseline helps, but it does not resolve every ambiguous case. This is one reason why some institutions have shifted from repeated skin tests to periodic IGRA blood tests for ongoing surveillance, since the blood test measures a different immune marker and is not affected by prior skin testing.
If you have had multiple TB skin tests and your latest reaction seems much bigger than previous ones, it does not automatically mean you were recently infected. But it does warrant a conversation with your provider about whether additional evaluation, such as a chest X-ray, is appropriate. The larger reaction might be nothing more than your immune system’s increasingly robust memory of a protein it has seen before.